O'Rourke & Company’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,247
Closed -$228K 126
2022
Q1
$228K Sell
5,247
-148
-3% -$6.41K 0.16% 113
2021
Q4
$268K Buy
+5,395
New +$279K 0.18% 105

Other funds holding HEAL

O'Rourke & Company's HEAL Position: Q2 2022 in Review

O'Rourke & Company sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q2 2022, closing a stake of 5,247 shares — an estimated $228K sold.

O'Rourke & Company first reported a position in HEAL in Q4 2021 and held it in 2 quarters. The position peaked at $268K in Q4 2021. 55 funds tracked by Wall St. Rank hold HEAL as of Q2 2022.

  • O'Rourke & Company reported no remaining Global X Funds Global X HealthTech ETF position as of Q2 2022 after selling out during the quarter.
  • O'Rourke & Company sold 5,247 Global X Funds Global X HealthTech ETF shares in Q2 2022, an estimated $228K.
  • O'Rourke & Company first reported a position in Global X Funds Global X HealthTech ETF in Q4 2021 and held it in 2 quarters.
  • O'Rourke & Company's Global X Funds Global X HealthTech ETF position peaked at $268K in Q4 2021.
  • 55 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q2 2022.

Based on O'Rourke & Company's 13F filing for Q2 2022, filed 12 Aug 2022.